PubMed · 2013 · 19 citations · 21 references
Open access
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurogeneticsGenetic DisordersMutation AnalysisNeurogenetic DisordersRare Disease GeneticsVariant ClassificationVariant InterpretationDeletionsFunctional MriGenotype Phenotype RelationshipGenotype-phenotype LandscapeGenotype-phenotype MappingMissense MutationsMutations In Notch Signaling Pathway
Some missense mutations and small deletions in the NOTCH3 gene, not involving cysteine residues, have been described in patients considered to be affected by paucisymptomatic CADASIL. However, the significance of such molecular variants is still unclear. We describe a 49-year-old woman with a CADASIL-like phenotype, carrying a novel cysteine-sparing mutation in exon 29 of the NOTCH3 gene, and discuss the possible pathogenetic role of this molecular variant. Even though atypical clinical and MRI findings make a diagnosis of CADASIL unlikely in this patient, our report nevertheless underlines the intriguing genotype-phenotype relationship in NOTCH3 mutations and the importance of functional investigation to ascertain the role of new NOTCH3 mutations in CADASIL pathogenesis.
21
The phenotypic spectrum of CADASIL: Clinical findings in 102 cases
Martin Dichgans, M. Mayer, Ingo Uttner et al. · Annals of Neurology · 1998 · 734 citations
Medicine, Neurology, Neuroscience +13
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
Anne Joutel, Katayoun Vahedi, Christophe Corpechot et al. · The Lancet · 1997 · 684 citations
Patterns of MRI lesions in CADASIL
Hugues Chabriat, C.D.P. Levy, H. Taillia et al. · Neurology · 1998 · 341 citations
Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
Anne Joutel, Pascal Favrole, Pierre Labauge et al. · The Lancet · 2001 · 254 citations
Medicine, Dermatology, Pathology +9